Prognostic significance of mild aortic regurgitation in predicting mortality after transcatheter aortic valve replacement.
Moderate to severe aortic regurgitation after transcatheter aortic valve replacement is associated with worse outcomes. The impact of mild aortic regurgitation has been less clear, possibly because of the broad categories that have been used in clinical trials, but holds increasing importance in the study of next-generation devices in low- and intermediate-risk cohorts. A more granular scheme, which is common in clinical practice and proposed for future trials, may add prognostic value.



We evaluated all patients undergoing transfemoral transcatheter aortic valve replacement at the Cleveland Clinic from 2006 to 2012. The degree of aortic regurgitation after transcatheter aortic valve replacement was reported from the echocardiography database based on a clinical, transthoracic echocardiogram performed within 30 days of the procedure. Aortic regurgitation was finely discriminated on the basis of a multiwindow, multiparametric, integrative approach using our usual clinical scale: none, trivial to 1+, 1+, 1 to 2+, 2+, 2 to 3+, 3+, 3 to 4+, or 4+.



There were 237 patients included in the analysis. By controlling for age, gender, Society of Thoracic Surgeons score, baseline ejection fraction, and aortic regurgitation before transcatheter aortic valve replacement, there was a significant increase in mortality for each half grade of aortic regurgitation compared with the complete absence of aortic regurgitation after transcatheter aortic valve replacement. The unit hazard ratio for each 1+ increase in aortic regurgitation after transcatheter aortic valve replacement was 2.26 (95% confidence interval, 1.48-3.43; P < .001) considering aortic regurgitation as a continuous variable. Other clinical variables did not significantly affect mortality.



Even mild aortic regurgitation after transcatheter aortic valve replacement is associated with worse long-term mortality. There may be prognostic value in reporting milder categories of aortic regurgitation with more granular gradations.
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.
Brandon M
BM
Jones
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.
E Murat
EM
Tuzcu
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.
Amar
A
Krishnaswamy
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.
Zoran
Z
Popovic
Department of Cardiothoracic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.
Stephanie
S
Mick
Department of Cardiothoracic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.
Eric E
EE
Roselli
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.
Sajjad
S
Gul
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.
Jasneet
J
Devgun
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.
Sohi
S
Mistry
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.
Wael A
WA
Jaber
Department of Cardiothoracic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.
Lars G
LG
Svensson
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio. Electronic address: kapadis@ccf.org.
Samir R
SR
Kapadia
D000369:Aged, 80 and over; D001022:Aortic Valve Insufficiency / Q000000981:diagnostic imaging / Q000401:mortality*; D001705:Bioprosthesis; D004452:Echocardiography; D005260:Female; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000401:mortality*; D011379:Prognosis; D012189:Retrospective Studies; D018570:Risk Assessment; D065467:Transcatheter Aortic Valve Replacement / Q000379:methods* / Q000401:mortality*; D016896:Treatment Outcome
aortic regurgitation; paravalvular regurgitation; transcatheter aortic valve; transcatheter aortic valve implantation; transcatheter aortic valve replacement